Abstract
Behavioral and psychological symptoms are common in dementia, challenging to manage, and a leading cause of nursing home placement, decreased quality of life, and caregiver distress. This chapter provides a seven-step model for tailoring treatment of five common behavioral and psychological symptoms of dementia (BPSD): agitation/irritability/aggression, depression and anxiety, apathy, sleep disturbance, and wandering. A review of nonpharmacological and pharmacological interventions and practical strategies for addressing BPSD in the context of neuropsychology practice are included.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
2016 Alzheimer’s disease facts and figures. https://www.alz.org/documents_custom/2016-facts-and-figures.pdf. Retrieved July 1, 2017.
Managing behavioral and psychological symptoms of dementia. http://www.alz.org/documents_custom/hcp_MD_BPSD.pdf. Retrieved July 1, 2017.
Cummings J, Lai TJ, Hemrungrojn S, Mohandas E, Yun Kim S, Nair G, et al. Role of donepezil in the Management of Neuropsychiatric Symptoms in Alzheimer’s disease and dementia with Lewy bodies. CNS Neurosci Ther. 2016;22:159–66.
Zhao QF, Tan L, Wang HF, Jiang T, Tan MS, Tan L, et al. The prevalence of neuropsychiatric symptoms in Alzheimer’s disease: systematic review and meta-analysis. J Affect Disord. 2016;190:264–71.
Borsje P, Wetzels RB, Lucassen PL, Pot AM, Koopmans RT. The course of neuropsychiatric symptoms in community-dwelling patients with dementia: a systematic review. Int Psychogeriatr. 2015;27:385–405.
van der Linde RM, Matthews FE, Dening T, Brayne C. Patterns and persistence of behavioural and psychological symptoms in those with cognitive impairment: the importance of apathy. Int J Geriatr Psychiatry. 2017;32:306–15.
Brodaty H, Connors MH, Xu J, Woodward M, Ames D. The course of neuropsychiatric symptoms in dementia: a 3-year longitudinal study. J Am Med Dir Assoc. 2015;16:380–7.
Apostolova LG, Di LJ, Duffy EL, Brook J, Elashoff D, et al. Risk factors for behavioral abnormalities in mild cognitive impairment and mild Alzheimer’s disease. Dement Geriatr Cogn Disord. 2014;37:315–26.
D’Onofrio G, Sancarlo D, Panza F, Copetti M, Cascavilla L, Paris F, et al. Neuropsychiatric symptoms and functional status in Alzheimer’s disease and vascular dementia patients. Curr Alzheimer Res. 2012;9:759–71.
Cohen-Mansfield J, Marx M, Dakeel-Ali M, Regier MG, Thein K. Can persons with dementia be engaged with stimuli? Am J Geriatr Psychiatry. 2010;18:351–62.
Guarlnik JM, Levielle S, Volpato S, Marx M, Cohen-Mansfield J. Targeting high-risk older adults into exercise programs for disability prevention. J Aging Phys Act. 2003;11:219–28.
Cohen-Mansfield J. Use of patient characteristics to determine nonpharmacologic interventions for behavioral and psychological symptoms of dementia. Int psycho geriatr. 2000;12:373–80.
Kales HC, Gitlin LN, Lyketsos CG. Assessment and management of behavioral and psychological symptoms of dementia. BMJ. 2015;350:h369.
Fisher JE, Harsin CW, Hayden JE. Behavioral interventions for patients with dementia. In: Molinari V, editor. Professional Psychology in long-term care. New York: Hatherleigh; 2000. p. 179–200.
Alzheimer’s Association 24/7 Helpline webpage. http://www.alz.org/we_can_help_24_7_helpline.asp. Accessed July 1, 2017.
Gitlin LN, Rose K. Impact of caregiver readiness on outcomes of a nonpharmacological intervention to address behavioral symptoms in persons with dementia. Int J Geriatr Psychiatry. 2016;31:1056–63.
Parker D, Mills S, Abbey J. Effectiveness of interventions that assist caregivers to support people with dementia living in the community: a systematic review. Int J Evid Based Healthc. 2008;6:137–72.
Health Quality Ontario. Caregiver- and patient-directed interventions for dementia: an evidence-based analysis. Ont Health Technol Assess Ser. 2008;8:1–98.
Cohen-Mansfield J, Marx M, Thein K, Dakeel-Ali M. The impact past and present preferences on stimulus engagement in nursing home residents with dementia. Age & Mental Health. 2010;14:67–73.
Cohen-Mansfield J, Thein K, Dakeel-Ali M, Marx M. The underlying meaning of stimuli: impact on engagement of persons with dementia. Psychiatry Res. 2010;177:216–22.
Chancellor B, Duncan A, Chatterjee A. Art therapy for Alzheimer’s disease and other dementias. J Alz Dis. 2014;39:1–11.
Camic PM, Tischler V, Pearman CH. Viewing and making art together: A multi-session art-gallery based intervention for people with dementia and their carers. Aging Ment Health. 2014;18:161–8.
Cohen-Mansfield J, Thein K, Dakeel-Ali M, Regier MG, Marx M. The value of social attributes of stimuli in promoting engagement in persons with dementia. J Nerv Ment Dis. 2010;198:586–92.
Abraha I, Rimland JM, Lozano-Montoya I, Dell’Aquila G, Vélez-Díaz-Pallarés M, Trotta FM, et al. Simeulated presence therapy for dementia. Cochrane database Syst rev. 2017;18:4.
Wu J, Wang Y, & Wang Z. The effectiveness of massage and touch on behavioural and psychological symptoms of dementia: a quantitative systematic review and meta-analysis. J Adv Nurs 2017;5. doi: https://doi.org/10.1111/jan.13311. [Epub ahead of print].
Abd El-Kader SM, Al-Jiffri OH. Aerobic exercise improves quality of life, psychological Well-being and systemic inflammation in subjects with Alzheimer’s disease. Afr Health Sci. 2016;16:1045–55.
Morris JK, Vidoni ED, Johnson DK, Van Sciver A, Mahnken JD, Honea RA, et al. Aerobic exercise for Alzheimer’s disease: a randomized controlled pilot trial. PLoS One. 2017;12:e0170547.
Cohen-Mansfield J, Lipson S. Pain in cognitively impaired nursing home residence: how well are physicians diagnosing it? J Am Ger Soc. 2002;50:1039–44.
McGee JS, Zhao HC, Myers DR, Kim SM. Positive psychological assessment and early-stage dementia. Clin Gerontol. 2017;9:1–13.
Millán-Calenti JC, Lorenzo-López L, Alonso-Búa B, de Labra C, González-Abraldes I, Maseda A. Optimal nonpharmacological management of agitation in Alzheimer’s disease: challenges and solutions. Clin Interv Aging. 2016;11:175–84.
Cohen-Mansfield J. Nonpharmacologic interventions for inappropriate behaviors and dementia: a review, summary, and critique. Am J Geriatr Psychiatry. 2001;9:361–81.
Cohen-Mansfield J, Liben A, Marx M. Nonpharmacologic treatment of agitation: A controlled trial of systematic individualized intervention. J Gerontol: Series A. 2007;62:908–16.
de Oliveira, Radanovic M, Homem de Mello PC, Buchain PC, Vizzotto ADB, Celestino DL et al. Nonpharmacological interventions to reduce behavioral and psychological symptoms of dementia: a systematic review. BioMed Res Intl. 2015;Art ID 218980.
Pedersen SKA, Andersen PN, Lugo RG, Andreassen M, Sütterlin S. Effects of music on agitation in dementia: a meta-analysis. Front Psychol. 2017;8:742.
Travers C, Brooks D, Hines S, O’Reilly M, McMaster M, He W, et al. Effectiveness of meaningful occupation interventions for people living with dementia in residential aged care: a systematic review. JBI Database System Rev Implement Rep. 2016;14:163–225.
Abraha I, Rimland JM, Trotta FM, Dell’Aquila G, Cruz-Jentoft A, Petrovic M, et al. Systematic review of systematic reviews of non-pharmacological interventions to treat behavioural disturbances in older patients with dementia. The SENATOR-OnTop series. BMJ Open. 2017;16:e012759.
Dourado MC, Laks J. Psychological interventions for neuropsychiatric disturbances in mild and moderate Alzheimer’s disease: current evidences and future directions. Curr Alzheimer Res. 2016;13:1100–11.
Moorman Li R, Gilbert B, Orman A, Aldridge P, Leger-Krall S, Anderson C, et al. Evaluating the effects of diffused lavender in an adult day care center for patients with dementia in an effort to decrease behavioral issues: a pilot study. J Drug Assess. 2017;6:1–5.
Ng QX, Ho CY, Koh SS, Tan WC, Chan HW. Doll therapy for dementia sufferers: a systematic review. Complement Ther Clin Pract. 2017;26:42–6.
Richeson NE. Effects of animal-assisted therapy on agitated behaviors and social interactions of older adults with dementia. Am J Alzheimers Dis Other Dem. 2003;18:353–8.
Liben A, Cohen-Mansfield J. Therapeutic robocat for nursing home residents with dementia: preliminary inquiry. Am J Alzheimers Dis Other Dem. 2004;19:111–6.
Steinberg M, Lyketsos CG. Atypical antipsychotic use in patients with dementia: managing safety concerns. Am J Psychiatr. 2012;169:900–6.
Dorsey RE, Rabbani A, Gallagher SA, Conti RM, Alexander GC. Impact of FDA black-box advisory on antipsychotic medication use. Arch Int Med. 2010;170:96–103.
Gabryelewicz T. Pharmacological treatment of behavioral symptoms in dementia patients. Przegl Lek. 2014;71(4):215–20.
Manabe Y, Ino T, Yamanaka K, Kosaka K. Increased dosage of donepezil for the management of behavioural and psychological symptoms of dementia in dementia with Lewy bodies. Psychogeriatrics. 2016;16:202–8.
Suzuki H, Inoue Y, Nishiyama A, Mikami K, Gen K. Clinical efficacy and changes in the dosages of concomitantly used psychotropic drugs in memantine therapy in Alzheimer’s disease with behavioral and psychological symptoms on dementia. Ther Adv Psychopharmacol. 2013;3:123–8.
Ballard CG, Gauthier S, Cummings JL, Brodaty H, Grossberg GT, Robert P, et al. Management of agitation and aggression associated with Alzheimer disease. Nat Rev Neurol. 2009;5:245–55.
Siddique H, Hynan LS, Weiner MF. Effect of a serotonin reuptake inhibitor on irritability, apathy, and psychotic symptoms in patients with Alzheimer’s disease. J Clin Psychiatry. 2009;70:915–8.
Leonpacher AK, Peters ME, Drye LT, Makino KM, Newell JA, Devanand DP. Effects of Citalopram on Neuropsychiatric Symptoms in Alzheimer’s Dementia: Evidence from the CitAD study. Am J Psychiatry. 2016;173:473–80.
Porsteinsson AP, Keltz MA, Smith JS. Role of citalopram in the treatment of agitation in Alzheimer’s disease. Neurodegener Dis Manag. 2014;4:345–9.
Porsteinsson AP, Antonsdottir IM. An update on the advancements in the treatment of agitation in Alzheimer’s disease. Expert Opin Pharmacother. 2017;18:611–20.
Isserles M, Daskalakis ZJ, Kumar S, Rajji TK, Blumberger DM. Clinical effectiveness and tolerability of electroconvulsive therapy in patients with neuropsychiatric symptoms of dementia. J Alzheimers Dis. 2017;57:45–51.
Teri L, Logsdon RG, Uomoto J, McCurry SM. Behavioral treatment of depression in dementia patients: a controlled clinical trial. J Gerontol B Psychol Sci Soc Sci. 1997;52B:P159–66.
Gómez GM, Gómez GJ. Music therapy and Alzheimer’s disease: cognitive, psychological, and behavioural effects. Neurologia. 2017;32:300–8.
Ray KD, Mittelman MS. Music therapy: a nonpharmacological approach to the care of agitation and depressive symptoms for nursing home residents with dementia. Dementia (London). 2015. pii: 1471301215613779. [Epub ahead of print].
Sánchez A, Maseda A, Marante-Moar MP, de Labra C, Lorenzo-López L, Millán-Calenti JC. Comparing the effects of multisensory stimulation and individualized music sessions on elderly people with severe dementia: a randomized controlled trial. J Alzheimers Dis. 2016;52:303–15.
Orgeta V, Tabet N, Nilforooshan R, Howard R. Efficacy of antidepressants for depression in alzheimer’s disease: systematic review and meta-analysis. J Alzheimers Dis. 2017;58:725–33.
Theleritis C, Siarkos K, Katirtzoglou E, Politis A. Pharmacological and nonpharmacological treatment for apathy in Alzheimer disease: a systematic review across modalities. J Geriatr Psychiatry Neurol. 2017;30:26–49.
Theleritis PA, Siarkos K, Lyketsos CG. A review of neuroimaging findings of apathy in Alzheimer’s disease. Int Psychogeriatr. 2014;26:195–207.
Brodaty HM, Burns KB. Nonpharmacological management of apathy in dementia: a systematic review. Am J Geriatr Psychiatry. 2002;20:549–64.
Ferrero-Arias J, Goñi-Imízcoz M, González-Bernal J, Lara-Ortega F, da Silva-González Á, Díez-Lopez M. The efficacy of non-pharmacological treatment for dementia related apathy. Alzheimer Dis Assoc Dis. 2011;25:213–9.
Deschenes CL, McCurry SM. Current treatments for sleep disturbances in individuals with dementia. Curr Psychiatry Rep. 2009;11:20–6.
McCleery J, Cohen DA, Sharpley AL. Pharmacotherapies for sleep disturbances in dementia. Cochrane Database Syst Rev. 2016;11:CD009178.
Davis R, Weisbeck C. Creating a supportive environment using cues for wayfinding in dementia. J Gerontol Nurs. 2016;42:36–44.
Topfer LA. GPS locator devices for people with dementia. In: CADTH Issues in Emerging Health Technologies. Canadian Agency for Drugs and Technologies in health: Ottawa (ON); 2016. p. 147.
Futrell MF, Devereaux Melillo K, Remington R. Evidence-based practice guideline: wandering. J Geron Nurs. 2014;40:16–23.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Braun, M. (2019). Management of Behavioral and Psychological Symptoms in Dementia. In: Ravdin, L.D., Katzen, H.L. (eds) Handbook on the Neuropsychology of Aging and Dementia. Clinical Handbooks in Neuropsychology. Springer, Cham. https://doi.org/10.1007/978-3-319-93497-6_23
Download citation
DOI: https://doi.org/10.1007/978-3-319-93497-6_23
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-93496-9
Online ISBN: 978-3-319-93497-6
eBook Packages: Behavioral Science and PsychologyBehavioral Science and Psychology (R0)